Current research indicates that the nucleocapsid protein (NCp7) of human immunodeficiency virus type 1 (HIV-1) interacts with a variety of RNA substrates during the progression of the viral life cycle. The RNA features specifically recognized by the protein, however, have yet to be identified. SELEX was used to generate a set of RNAs whose affinities for nucleocapsid were on the order of 2 1 10 09 M. Comparative analysis revealed that each RNA contains a highly conserved fourteen nucleotide sequence-block. Computer modeling and structure probing experiments indicate that the RNA ligands use the consensus sequence to fold into hairpins with an identical asymmetric bulge. The presence of the nucleocapsid protein protects the asymmetric bulge from ribonuclease attack, suggesting that it is the key element in protein recognition. A search for similar structural motifs within the HIV genome reveals several potential interaction sites for the nucleocapsid protein. ᭧
INTRODUCTION
with reverse transcriptase which influence strand transfer and transcription rate (Weiss et al., 1992 ; Peliska et One of the first events during the replication of HIV -1 al., 1994; Rodriguez-Rodriguez et al., 1995; Ji et al., 1996) . and all other known retroviruses is conversion of genoRetroviral nucleocapsid proteins are precursor prodmic RNA to DNA using the viral reverse transcriptase ucts (Mervis et al., 1988; Morellet et al., 1992) . HIV-1 (RT) and other host cell components (for review; Coffin, nucleocapsid protein contains two zinc finger binding 1982; Varmus and Brown, 1989; Wain-Hobson, 1994) . The domains with the general structure Cys-X 2 -Cys-X 4 -Hisviral RNA is reverse transcribed by RT with a host tRNA X 4 -Cys (Gorelick et al., 1993) . Mutations in each of these being used as the primer (reviewed in Wong-Staal, 1990;  finger domains result in different functional and structural Vaishnav and Wong-Staal, 1991) . Retroviral nucleocapsid defects (Gorelick et al., 1990 (Gorelick et al., , 1993 Julian et al., 1993) . proteins are intimately involved in annealing of the tRNA Similar types of mutations in RSV and MuLV nucleocapprimer to the genomic RNA. It has been reported that sid proteins result in defects in RNA packaging and dimer nucleocapsid proteins from Mason-Pfizer monkey virus formation (Mé ric and Spahr, 1986; Mé ric and Goff, 1989) . (MPMV) and HIV-1 facilitate primer annealing (Dib-Hajj Results from these studies suggest a role for the nucleoet al., 1993; Tsuchihashi and Brown, 1994; Lapadat-Ta- capsid protein during reverse transcription (Mé ric and polsky et al., 1995) . Moreover, it has been shown that Goff, 1989; Weiss et al., 1992) and possibly during infecthe nucleocapsid proteins of Rous sarcoma virus (RSV) tion (Mé ric and Spahr, 1986) . and murine leukemia virus (MuLV) are directly involved Sequences near the 5 end of the mature HIV-1 viral in annealing the tRNA primer onto the primer binding RNA are apparently involved in encapsidation (Aldovini site under physiological conditions (Prats et al., 1988; and Young, 1990 ). It appears these sequences interact Barat et al., 1989) . NC proteins from the human immunospecifically with the nucleic acid binding zinc finger dodeficiency virus have also been implicated in dimerizamains of HIV-1 NC. Mutations in either of the two Zn // tion of genomic RNA (Darlix et al., 1990; Sakaguchi et fingers or the encapsidation site result in similar defects. al., 1993), encapsidation of full-length genomic RNA (Rizvi The 5 end of retroviral RNAs have been rigorously studand Panganiban, 1993; South and Summers, 1993; Zhang ied and thus the structural and functional characterizaand Barklis, 1995; Tanchou et al., 1995) , and interactions tion is extensive (Bender et al., 1978; Murti et al., 1981; Darlix et al., 1982; Aldovini and Young, 1990; Harrison and Lever, 1992; Surovoy et al., 1993 To better understand the specific RNA features recogthrough 8, 250 pmol of the selected RNA was used with labeled RNA from that pool to follow the amount of recovnized by the nucleocapsid protein, we used SELEX to generate a set of RNA molecules with high affinity for ery. In each round, other than round 1, we selected about 3% of the total input RNA or a smaller fraction if counts the HIV-1 protein. Sequence comparison and structural characterization of the RNAs identified a consensus bindwere greater than 10-fold above the control (cpm bound in the absence of protein). For rounds 9 and 10 we reing site of the nucleocapsid protein. A search of the HIV genome for structures resembling the SELEX-generated duced the amount of RNA to 25 pmol. During the last 7 rounds (rounds 11-17), 25 pmol of cold-selected RNA consensus revealed several potential targets for the protein.
was used along with 500 pmol of a nonamplifiable random pool of competitor RNA as described (Allen et al., 1995) .
MATERIALS AND METHODS

PCR amplification and selection
Expression constructs Amplification by PCR and the SELEX procedure were
The capsid-nucleocapsid (CA-NC) and nucleocapsid carried out essentially as described (Tuerk and Gold, (NC) segments of the HIV-1 gag protein were amplified 1990). Five picomoles of a random pool of DNA oligomers from the clone pBH10 (Ratner et al., 1985) and inserted were used as template for PCR amplification for 8 cycles downstream of the phage T7 promoter of the multicopy in the initial round. Complementary DNA of the selected expression vector pGZ/H6, derived from the phagemid pool of RNA from subsequent rounds of SELEX was PCR pTZ18R (Mead et al., 1986) . The plasmid pGZ/H6CANC-amplified 18 cycles. PCR reactions were carried out in 6 expressed a fusion protein in which an N-terminal 50-ml volumes containing 200 pmol of each primer, 2 mM hexahistidine tag (MKLHHHHHHGY) was followed by dNTP's, 5 units of Thermus aquaticus DNA polymerase residues Gln127 through Asn432 of HIV-1 gag. The plas-(Perkin-Elmer-Cetus) in PCR buffer (10 mM Tris-Cl, mid pGZ/NC55-1 expressed a 55-residue form of NC pH 8.4, 50 mM KCl, 7.5 mM MgCl 2 , 0.05 mg/ml BSA).
starting from the naturally occurring Met378 through Conditions used for primer annealing, extension, and deAsn432 of HIV-1 gag. An Escherichia coli K12 strain naturation of DNA strands are identical to those pre-AP401K harboring plasmids pGZ/H6CANC6 or pGZ/ viously described (Allen et al., 1995) .
NC55-1 was induced for expression with bacteriophage PCR products were transcribed using T7 RNA polymermGP1-2 (gift from S. Tabor), an M13 derivative containing ase in vitro in a 200-ml reaction volume (Tuerk and Gold, the gene for T7 RNA polymerase, as described (Hostom-1990) . T7 transcripts were purified from a 6% polyacrylsky et al., 1989) . amide, 7 M Urea gel and eluted by crushing gel pieces in a Sodium Acetate/EDTA solution. For each round of Purification of nucleocapsid p7 SELEX, 50 pmol of the selected pool of RNA was phosphatased using Calf Intestinal Alkaline Phosphatase
The E. coli cells, harvested 3 hr after induction, were (Biolabs) and 25 pmol was 5 end-labeled using [g-32 P]-resuspended in 50 mM Tris/HCl, pH 8.0, and lysed in a ATP with polynucleotide kinase (Boehringer) for 30 min.
microfluidizer (Microfluidics Corp.) . After removal of cell Kinased RNA was purified and about 150,000 cpm was debris by centrifugation, the nucleic acids were precipiused to follow the fraction of RNA retained on nitrocellutated from the soluble lysate by stepwise addition of lose filters during selection. Protein and nucleic acid conPolymin P to a final concentration of 0.5%. Powdered ditions for selection and elution of RNA from nitrocelluammonium sulfate was added to the supernatant to a lose filters were as described (Allen et al., 1995) .
final concentration of 40%. Upon removal of pellet by centrifugation, more ammonium sulfate was added to Selection in the presence of nonamplifiable the supernatant until its concentration reached 80%. The competitor RNA pellet was taken up in 50 mM Tris/HCl, pH 8.0, 5 mM 2-mercaptoethanol, 10% glycerol, and 50 mM NaCl (Buffer Selections were done using two buffer conditions where the only difference between the buffers was the C). After dialysis against buffer C, the sample was applied to a FPLC MonoQ column (Pharmacia). The flowconcentration of NaCl (Buffer A, 10 mM NaOAc (pH 5.3), 2 mM 2-mercaptoethanol, 0.1 mM ZnCl 2 , 5 mM MgCl 2 , through fractions were pooled and applied directly to an FPLC MonoS column (Pharmacia). The protein was 200 mM NaCl; Buffer B, 10 mM NaOAc (pH 5.3), 2 mM 2-mercaptoethanol, 0.1 mM ZnCl 2 , 5 mM MgCl 2 , 400 mM released by a linear gradient of 50 mM-1 M NaCl in buffer C. The pooled nucleocapsid containing fractions NaCl). The parent pool (500 pmol) of RNA was used in the first round of selection along with about 100 fmol of were dialysed against buffer D (25 mM Tris/HCl, pH 8.0, 50 mM NaCl, 2 mM 2-mercaptoethanol, and 0.1 mM g-labeled RNA from the same pool. RNA was recovered and cDNA synthesized and PCR amplified. In rounds 2
ZnCl 2 ) and concentrated to 1.7 mg/ml.
Purification of capsid-nucleocapsid fusion protein twice, and chloroform extracted, and the fragments were precipitated with ethanol. Soluble lysate of E. coli harboring pGZ/H6CANC-6, prepared as in the NC purification described above, was
Chemical and enzymatic modification applied to a Ni // -NTA-agarose column (Quiagen). The of selected RNAs column was washed extensively with 20 mM Tris/HCl, RNAs were partially digested using ribonuclease S1 pH 8.0, containing 1 M NaCl, followed by 20 mM Tris/ (0.2 units/reaction). For each enzymatic digestion carried HCl, pH 8.0. The bound CANC fusion protein was eluted out with NC present in the reaction mixture, the concenwith a linear gradient of 1-200 mM imidazole in 20 mM tration of protein varied from 0.05 mM to 10 mM and the Tris/HCl buffer (pH 8.0). The CANC (released at approxiamount of RNA used was 4 pmol per reaction. Nucleomately 60 mM imidazole concentration) was dialysed capsid and RNA was incubated together in binding buffer against buffer D. at 37Њ for 20 min then transferred to ice for 5 min before adding RNase S1 for an additional 5 min. The RNase S1 Cloning and sequencing was preincubated at 4Њ before adding to reactions. The PCR amplified DNA from the round 16 selected-pool mix was phenol extracted three times, chloroform exof RNA was phenol and chloroform extracted and ethanol tracted twice, ethanol precipitated, and stored at 020Њ. precipitated. The extracted PCR DNA was digested using Primer extensions (Stern et al., 1988) were done the day BamHI and HindIII (Biolabs) and subcloned into pUC18.
of nuclease treatment to identify positions that are accesLigation was carried out at room temperature for 2 hr, sible to the enzyme. after which the reaction was phenol and chloroform extracted and used to electroporate competent cells.
In vitro inhibition assay Twenty-five transformants from the SELEX performed in
The 5 end of the synthetic DNA oligonucleotide, the low salt buffer and 30 from the high salt experiment Con/, (5-CAATGACCGCATGGGATCCGTGTGGAAAATwere picked and their DNAs sequenced.
CTCTAGCAGT-3) was labeled with [g-32 P]ATP using polynucleotide kinase (Boehringer). Labeled con/ (10 Binding assays nM) was incubated at 37Њ with equimolar ratio of the Binding assays were done by adding 5 ml of HIV-1 complementary strand, con0, in binding buffer connucleocapsid p7 protein, at the appropriate concentrataining various concentrations of NaCl for 6 min and then tions, to 45 ml of binding buffer (10 mM NaOAc (pH 5.3), run on an 8% native acrylamide gel to determine the salt 2 mM 2-mercaptoethanol, 0.1 mM ZnCl 2 , 5 mM MgCl 2 , concentration that provides approximately 50% duplex. 100 mM NaCl) on ice, then adding 80,000 cpm of kinased Binding buffer containing 200 mM NaCl converted 40 to RNA (õ200 fmol) in a volume of 3 to 4 ml. This mix was 70% labeled con/ to duplex. This buffer was used and incubated at 37ЊC for 20 min. The reactions were passed the concentration of each oligo was reduced keeping the over nitrocellulose filters that had been preequilibrated reaction time constant to find an oligo concentration that in the same buffer. The protein bound filters were would give less than 10% duplex formation under these washed five times with one milliliter of 50 mM Tris-Cl, conditions. pH 7.5, solution. Filters were dried and counted in cock-
The conditions in the reaction used for the inhibition tail. The protein used in these experiments was frozen assay were as follows. Four hundred picomoles of each and thawed only once. Dissociation constants were de-DNA oligo (con//0) was mixed with 10 nM nucleocapsid termined as previously described (Carey et al., 1983) .
for 6 min at 37Њ in binding buffer containing 200 mM NaCl in a reaction volume of 30 ml. After this time, reacDetermination of the minimum binding domain tions were stopped by placing on ice and loaded on gel after 2 min. Gels were run at 250 V for 3.5 hr. In reactions Boundary determination experiments were carried out where random RNA was added as inhibitor, the concenessentially as previously published trations ranged from 6500 nM to 9 nM. Where selected with the following exceptions. Our transcripts were RNAs were used, the range was 720 nM to 0.11 nM. treated with calf intestinal alkaline phosphatase (Biolabs). For each reaction, 25 pmol of partially hydrolyzed Synthesis of RNA truncates RNA was incubated with nucleocapsid protein in binding buffer in a final reaction volume of 50 ml. Nucleocapsid
Primers that anneal at approximately 10 nucleotide increments from the 3 end of the 400-23 RNA were used concentrations were 0.5 1 10 09 , 1 1 10 09 , and 5 1 10 09 in each case. Reactions were quenched as previously to synthesize cDNAs. Primers and RNAs were heated to 90Њ and cooled slowly to 45Њ to anneal and primer extendescribed (Chen and Gold, 1994) . RNA fragments retained on filters were eluted using 150 ml of 1% SDS/0.3 sion was carried out at 48Њ. cDNAs were then PCR amplified using the same 3 primers with the original 5 primer. M NaOAc/1 mM EDTA solution, then phenol extracted Note. Bases in italics are fixed positions used for PCR amplification. Nucleotides that are highly conserved are underlined. In addition to being underlined, the fourteen nucleotide block is also in bold face. Numbers to the left of sequences represent the number of isolates bearing this sequence. All sequences are presented in a 5 to 3 orientation.
The resulting product was used to transcribe 3 truncated These experiments were carried out in duplicates. All binding curves were done using g-32 P-labeled RNA in RNAs. In addition to in vitro transcriptions, the shortest truncate (T-23) was also made synthetically.
binding buffer containing 100 mM NaCl. Dissociation constants (K d s) ranged from 2 to 6 nM ( Fig. 1 ). K d s of the two round 16 selected pools of RNA for nucleocapsid RESULTS protein were likewise under 10 nM (data not shown).
Sequence analysis
The K d for the initial random pool of RNA in the same buffer could not be determined since there was no Sequencing a total of 55 clones isolated after 16 complete rounds of SELEX resulted in multiple copies of 14 significant binding above background at the highest protein concentration (10 07 M). distinct sequences (Table 1) . Each sequence includes a 14-nucleotide block which is nearly identical. This highly Binding affinities were determined for 6 of the 12 conserved 14-base sequence-block occurs at different positions within the randomized region. Six of the isolates have single-base substitutions within the 14-nucleotide sequence-block ( Table 1) . Five of these are single base substitutions (U to A) at the ninth position of the block, while the other is a C to U base change at the fourteenth position. All other positions in the conserved block are identical among the clones. Besides the conserved sequence-block there is no other sequence homology shared among the selected sequences with the exception of a highly conserved cytosine at the last position of the random region. In general, the conserved sequence is located proximal to the 5 end of the random region. cies were determined by nitrocellulose filter binding. isolates for a precursor fusion protein derived from actions are G-C base pairs. There is good support for this structure from experiments using structure-sensitive the HIV-1 gag region [CA-NC; Capsid (p24) fused to Nucleocapsid (p7)]. The 322 amino acid polypeptide probes and primer extension (Fig. 5) . Because all of the stem regions involve base-pairing with bases that were product, which includes the entire 55 amino acid sequence of the NC used in the SELEX experiments, had fixed, there is no comparative evidence to support our model. no detectable binding affinity for these RNAs (data not shown). Two possible explanations for this result are that the RNA binding site of nucleocapsid is blocked in Boundary analysis the fusion protein, or the conformation of nucleocapsid Boundary experiments were carried out in order to within the fusion is altered yielding a protein that lacks determine the minimum RNA structure required for bindthe RNA binding site. SELEX was carried out using the ing to HIV-1 nucleocapsid protein. The 5-end-labeled same gag fusion protein and the winning ligands from RNAs were partially alkaline hydrolyzed and the fragthose experiments bear no resemblance to the NC liments were incubated with nucleocapsid protein and gands (Allen, Liss, and Gold, unpublished) . passed over nitrocellulose filters. Fragments with affinities high enough to survive washes were retained. These RNA structure analysis RNAs were eluted from the filters and analyzed on acryl-RNA transcripts of the individual clones were seamide gels. In every case, the deletion of nucleotides quenced directly and entered into the Zuker folding profrom the 3 end is tolerated up to, but not including, the gram. The algorithm predicted that all 55 clones folded last nucleotide in the sequence block (Fig. 3) . In other into the same secondary structure. The energy minimizawords, full-length RNAs and molecules bearing sequention for each RNA molecule was calculated to be 011 tial deletions from the 3 end are bound by nucleocapsid kcal/mol or better. The consensus structure was a stem and retained on filters except for deletions into the conformed between the first 10 nucleotides at the fixed 5 served 14-nucleotide block (Fig. 3) . This indicates that end and 10 of the 14 nucleotides from the conserved the stem between the 5 end and the nucleotides of the block with a loop that varied in size from 13 nucleotides 3 end of the conserved block is required for high affinity (clone 400-23) to 23 nucleotides (clone 400-18). In the binding. When the 3 end is labeled and the same hydrocenter of the 10-bp stem is a 4-base internal bulge whose lysis and binding experiments are carried out, only intact primary sequence, 5AACU3, is highly conserved (Fig. RNAs were retained on filters (data not shown). Thus, 2). The balance of the nucleotides that were originally any deletion at the 5 end results in failure to bind the randomized are modeled as an unstructured region. The nucleocapsid protein. highly conserved cytosine at the last position in the random region is paired with a G in the 3-fixed region.
Binding studies of RNA truncates The rest of the 3-fixed nucleotides fold into two hairpin structures with the terminal 3 C unpaired. There are
The minimum binding domain predicted by the boundary analysis for the RNA identified as 400-23 was used two noncanonical G-U pairs in the consensus structure. Approximately 75% of the modeled Watson-Crick interfor further characterization of the RNA binding site. This RNA fragment, referred to as T-23, is 37 nucleotides long.
29 (BC48) nucleotides from the 3 end resulted in slight, though significant decreases in affinity (Fig. 4) . Removal In addition to this fragment, we made an RNA where the loop was substituted with a UUCG tetra-loop resulting in of an additional 11 nucleotides (T-23; minimum binding domain) caused binding to drop drastically. Although Ta fragment 28 nucleotides long (BC2). Both of these RNAs were synthesized on an Applied Biosystems Model 394 23 binds to the nucleocapsid protein tighter than the parent pool (30N RNA), its dissociation constant is sur-DNA/RNA synthesizer as well as transcribed in vitro from PCR products. Neither of the truncates bound the nucleoprisingly greater than 400-23 (Fig. 4) . All truncated RNA fragments were sequenced directly to confirm their size capsid protein as well as the full-length RNA, therefore other truncates were made and their K d s were deterand sequence (data not shown). The fragment containing the tetra-loop (BC2) bound with an affinity similar to that mined.
Truncated molecules containing the 5 68, 48, and 37 of T-23. nucleotides (Fig. 4) were generated by transcribing synNucleocapsid footprints on the RNA thetic oligonucleotides. Comparing the K d s of these truncates for the nucleocapsid protein to that of the full-
The physical binding site of the nucleocapsid protein length RNA revealed that deletions of nine (BC68) and on one of the SELEX-generated RNAs (400-23) was determined by nuclease footprinting. Four regions of the RNA are shielded from digestion by S1 nuclease by varying concentrations of the nucleocapsid protein. At NC concentrations as low as 50 nM, sites in the conserved AACU bulge are protected from cleavage while remote nuclease-sensitive sites require up to 10 mM nucleocapsid to display protection (Fig. 5) . Nucleocapsid footprints that are observed at high concentrations are seen both 5 and 3 of the bulge. If protein-protein interactions are important for binding to the low affinity sites, then the highly conserved four base bulge may serve as the nucleation site for cooperative binding. Our results are consistent with the estimated occlusion size of seven to eight the filter retention efficiency brought about by multiple Annealing assays, as described above, were carried out in the presence of 30N, 400-17, and 400-23 RNAs to proteins binding to a single RNA.
determine the extent to which they inhibited the function In vitro inhibition of annealing function of the nucleocapsid protein. All three RNA samples were able to inhibit HIV-1 nucleocapsid protein-dependent anIf the RNA ligands are binding a site on NCp7 that is nealing, but the two selected RNAs inhibited at concenused for substrate recognition, then the ligands should trations which were orders of magnitude lower than that act as inhibitors. An assay for one of the proposed activiof the parent pool of RNA (Fig. 7) . It took concentrations ties of nucleocapsid, stimulation of nucleic acid annealof 30N RNA of 722 nM or greater to inhibit the annealing ing, was developed to test the inhibition efficiency of the activity of nucleocapsid in binding buffer containing 100 ligands. Complementary nucleic acids, con/ and con0, mM NaCl. For clones 400-17 and 400-23, the extent of are converted to the con//0 double-stranded form in 6 inhibition was much greater. 400-17 was able to inhibit min when nucleocapsid is present in the reaction at 100 approximately 50% of the annealing activity of nucleocapnM or greater (Fig. 6 ). Nucleocapsid concentrations of sid at a concentration of 0.5 nM, while the K i for 400-23 10 nM result in about a 60% conversion while 1 nM was 3 nM (Fig. 7 ). The observation of K i 's for these ligands nucleocapsid results in a mild increase in doublethat are lower than their observed K d s might be explained stranded DNA formation above the minus-nucleocapsid by the apparent cooperative binding observed in the footbackground level.
printing experiments above, as a single ligand could bind and inhibit multiple proteins.
DISCUSSION
As a first step toward understanding the RNA substrate binding specificity of the HIV-1 nucleocapsid protein p7, we generated RNA ligands to the viral protein using the SELEX protocol. All of the ligands that resulted from the selection contained a highly conserved 14-nucleotide block. Computer modeling and structure probing experi- for the nucleocapsid protein. This idea is corroborated by boundary and protein footprinting data. The fact that all of the ligands utilized the 5 most nucleotides in the RNA molecules does not necessarily reflect a need for the structure to occur at the 5 terminus of an RNA in order to generate high affinity binding. Molecules using the 5-fixed region to form one-half of the hairpin are expected to be more than a thousand-fold more prevalent in the initial RNA population than those molecules that form the structure using only nucleotides within the random region.
Two regions of the HIV-1 genome that are thought to interact with the nucleocapsid protein, the primer binding site (PBS) where tRNA 3
Lys anneals prior to cDNA synthesis and a domain implicated in encapsidation (Aldovini and Young, 1990; Clavel and Orenstein, 1990) , were searched for potential nucleocapsid binding sites. AACU sequences or minor variations of this sequence were sought out within or near these two areas, and the sur- The search identified several primary sequences that
The primer binding site spans the RNA from positions 107-125; the could form structures that were very similar to the SELEXencapsidation domain is suspected to occur between nucleotides 223 generated consensus (Fig. 8) . We have no physical eviand 337 (nucleotide positions taken from Ratner et al., 1985) . Structures dence for the existence of these structures in the PBS A and B flank the primer binding site, while structure C is located in the putative encapsidation region.
or encapsidation region. However, it is tempting to spec-L. E., and Rein, A. (1990) . Noninfectious human immunodeficiency ulate on a model where nucleocapsid protein binds these virus type 1 mutants deficient in genomic RNA. J. Virol. 64, elements during the life cycle of the virus and exert its 3211. effects on the various NC-mediated events. In our model, Gorelick, R. J., Chabot, D. J., Rein, A., Henderson, L. E., and Arthur, L. O. nucleocapsid protein binds these structures and localize (1993) . The two zinc fingers in the human immunodeficiency virus the involved components to these regions of the genomic type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67, [4027] [4028] [4029] [4030] [4031] [4032] [4033] [4034] [4035] [4036] RNA. Since our SELEX-generated ligands are inhibitors Harrison, G. P., and Lever, A. M. L. (1992) . The human immunodefiof the annealing activity of the NC in vitro, these RNAs ciency virus type 1 packaging signal and major splice donor region could prove to be useful therapeutic agents. It would be have a conserved stable secondary structure. J. Virol. 66, [4144] [4145] [4146] [4147] [4148] [4149] [4150] [4151] [4152] [4153] interesting to learn about the effects of these ligands on Hostomska, Z., Matthews, D. A., Davies, J. F. II., Nodes, B. R., and Hosother NC-mediated activities. tomsky, Z. (1991) . Proteolytic release and crystallization of the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 266, 14697-14702. 
